JBHT
49
3
VNO
59
3
BLK
69
2
M
14
2
EA
44
-2
CMG
50
-6
TGNA
51
3
MA
65
-4
BAX
35
-3
PAYX
53
-4
LYB
44
-2
GD
57
-2
SPG
53
-2
DOV
63
-6
TAP
51
-2
GRMN
50
-2
TXT
58
-2
AAL
47
-3
GT
46
3
NRG
57
2
JBHT
49
3
VNO
59
3
BLK
69
2
M
14
2
EA
44
-2
CMG
50
-6
TGNA
51
3
MA
65
-4
BAX
35
-3
PAYX
53
-4
LYB
44
-2
GD
57
-2
SPG
53
-2
DOV
63
-6
TAP
51
-2
GRMN
50
-2
TXT
58
-2
AAL
47
-3
GT
46
3
NRG
57
2
Financhill
Back

Krystal Biotech Quote, Financials, Valuation and Earnings

"EarnPhone": The Investment Hidden in Plain Sight

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
29

KRYS
Krystal Biotech

Last Price:
189.29
Seasonality Move:
14.77%

7 Day Trial

ALL ACCESS PASS

$ 7

How to Profit From "America's Earnings" Reports

New Trade Goes LIVE THIS TUESDAY at 2 pm

Krystal Biotech Price Quote

$189.29
+6.55 (+3.58%)
(Updated: September 19, 2024 at 12:55 PM ET)

Krystal Biotech Key Stats

Sell
29
Krystal Biotech (KRYS) is a Sell
Day range:
$182.19 - $190.84
52-week range:
$93.95 - $219.34
Dividend yield:
0%
P/E ratio:
468.56
P/S ratio:
32.06
P/B ratio:
6.26%
Volume:
335K
Avg. volume:
212.4K
1-year change:
54.2%
Market cap:
$5.3B
Revenue:
$50.7M
EPS:
$3.66

How Much Does Krystal Biotech Make?

Is Krystal Biotech Growing As A Company?

Data Unavailable

Krystal Biotech Stock Price Performance

  • Did Krystal Biotech Stock Go Up Last Month?
    Krystal Biotech share price went down by -5.02% last month
  • Did KRYS's Share Price Rise Over The Last Year?
    KRYS share price rose by 54.2% over the past 1 year

What Is Krystal Biotech 52-Week High & Low?

Krystal Biotech Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Krystal Biotech?

  • How Much Debt Does Krystal Biotech Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Krystal Biotech Have?
    Cash and short term investments quarterly total is $559.6M
  • What Is Krystal Biotech’s Book Value Per Share?
    Book value per share is 29.22

Is Krystal Biotech Cash Flow Positive?

  • What Is KRYS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$16.7M
  • What Is Krystal Biotech’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $37.2M
  • What Is Krystal Biotech’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $49.7M

Krystal Biotech Return On Invested Capital

  • Is Management Doing A Good Job?
    KRYS return on invested capital is 13.36%
  • What Is Krystal Biotech Return On Assets?
    ROA measures how assets are converting to revenues and is 12.54%
  • What Is KRYS Return On Equity?
    ROE is a measure of profitability and is 13.85%

Krystal Biotech Earnings Date & Stock Price

Krystal Biotech Competitors

  • Who Are Krystal Biotech's Competitors?
    Below is a list of companies who compete with Krystal Biotech or are related in some way:
    • Axsome Therapeutics Inc (AXSM)
    • Biomarin Pharmaceutical Inc (BMRN)
    • Janux Therapeutics Inc (JANX)
    • Keros Therapeutics Inc (KROS)
    • Sarepta Therapeutics Inc (SRPT)

Krystal Biotech Dividend Yield

Krystal Biotech Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -5.88%
Revenue: 0% 7.36%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 207.22
Upside from Last Price: 13.4%

Major Shareholders

  • How many KRYS shares are owned by institutional investors?
    52.9M KRYS shares are owned by institutional investors
  • How many KRYS shares are owned by insiders?
    3.5M KRYS shares are owned by insiders